SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism

Steven A. Lietman, Nichole L. Prescott, David G. Hicks, William H. Westra, Michael A. Levine

Research output: Contribution to journalArticle

Abstract

Giant cell tumor of bone and giant cell reparative granuloma are benign lesions with prominent giant (multinucleated) cells, and an understanding of the molecular biology and genetics of these lesions will likely aid in more effective treatment. Cherubism is a benign lesion of the maxilla and mandible histologically similar to giant cell tumor of bone and giant cell reparative granuloma. Germline mutations in exon 9 of the gene encoding Src homology 3 binding protein 2 (SH3BP2) occur in most patients with cherubism. We therefore hypothesized SH3BP2 and its putative downstream effector nuclear factor of activated T cells c1 isoform (NFATc1) are highly expressed in sporadic nonsyndromic giant cell lesions and associated with somatic SH3BP2 mutations. We analyzed giant cell lesions for SH3BP2 and NFATc1 expression by RNA blot and/or immunohistochemistry and for exon 9 SH3BP2 mutations. We found the SH3BP2 transcripts and protein were abundantly expressed in giant cell tumors of bone, as well as NFATc1 protein. Sequencing of exon 9 of SH3BP2 was normal in all sporadic nonsyndromic giant cell lesions. Although many multinucleated giant cell lesions of bone share histologic features, the primary genetic defect in cherubism and these other giant cell lesions appears different.

Original languageEnglish (US)
Pages (from-to)22-27
Number of pages6
JournalClinical Orthopaedics and Related Research
Issue number459
DOIs
StatePublished - Jun 2007

Fingerprint

Cherubism
Giant Cells
Exons
Carrier Proteins
Giant Cell Tumor of Bone
NFATC Transcription Factors
Giant Cell Granuloma
Molecular Biology
Protein Isoforms
src Genes
RNA Isoforms
Mutation
Germ-Line Mutation
Maxilla
Mandible
Immunohistochemistry
Bone and Bones

ASJC Scopus subject areas

  • Surgery
  • Orthopedics and Sports Medicine

Cite this

SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism. / Lietman, Steven A.; Prescott, Nichole L.; Hicks, David G.; Westra, William H.; Levine, Michael A.

In: Clinical Orthopaedics and Related Research, No. 459, 06.2007, p. 22-27.

Research output: Contribution to journalArticle

Lietman, Steven A. ; Prescott, Nichole L. ; Hicks, David G. ; Westra, William H. ; Levine, Michael A. / SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism. In: Clinical Orthopaedics and Related Research. 2007 ; No. 459. pp. 22-27.
@article{967a81a954254f7ba78f06d797c28d77,
title = "SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism",
abstract = "Giant cell tumor of bone and giant cell reparative granuloma are benign lesions with prominent giant (multinucleated) cells, and an understanding of the molecular biology and genetics of these lesions will likely aid in more effective treatment. Cherubism is a benign lesion of the maxilla and mandible histologically similar to giant cell tumor of bone and giant cell reparative granuloma. Germline mutations in exon 9 of the gene encoding Src homology 3 binding protein 2 (SH3BP2) occur in most patients with cherubism. We therefore hypothesized SH3BP2 and its putative downstream effector nuclear factor of activated T cells c1 isoform (NFATc1) are highly expressed in sporadic nonsyndromic giant cell lesions and associated with somatic SH3BP2 mutations. We analyzed giant cell lesions for SH3BP2 and NFATc1 expression by RNA blot and/or immunohistochemistry and for exon 9 SH3BP2 mutations. We found the SH3BP2 transcripts and protein were abundantly expressed in giant cell tumors of bone, as well as NFATc1 protein. Sequencing of exon 9 of SH3BP2 was normal in all sporadic nonsyndromic giant cell lesions. Although many multinucleated giant cell lesions of bone share histologic features, the primary genetic defect in cherubism and these other giant cell lesions appears different.",
author = "Lietman, {Steven A.} and Prescott, {Nichole L.} and Hicks, {David G.} and Westra, {William H.} and Levine, {Michael A.}",
year = "2007",
month = "6",
doi = "10.1097/BLO.0b013e31804b4131",
language = "English (US)",
pages = "22--27",
journal = "Clinical Orthopaedics and Related Research",
issn = "0009-921X",
publisher = "Springer New York",
number = "459",

}

TY - JOUR

T1 - SH3BP2 is rarely mutated in exon 9 in giant cell lesions outside cherubism

AU - Lietman, Steven A.

AU - Prescott, Nichole L.

AU - Hicks, David G.

AU - Westra, William H.

AU - Levine, Michael A.

PY - 2007/6

Y1 - 2007/6

N2 - Giant cell tumor of bone and giant cell reparative granuloma are benign lesions with prominent giant (multinucleated) cells, and an understanding of the molecular biology and genetics of these lesions will likely aid in more effective treatment. Cherubism is a benign lesion of the maxilla and mandible histologically similar to giant cell tumor of bone and giant cell reparative granuloma. Germline mutations in exon 9 of the gene encoding Src homology 3 binding protein 2 (SH3BP2) occur in most patients with cherubism. We therefore hypothesized SH3BP2 and its putative downstream effector nuclear factor of activated T cells c1 isoform (NFATc1) are highly expressed in sporadic nonsyndromic giant cell lesions and associated with somatic SH3BP2 mutations. We analyzed giant cell lesions for SH3BP2 and NFATc1 expression by RNA blot and/or immunohistochemistry and for exon 9 SH3BP2 mutations. We found the SH3BP2 transcripts and protein were abundantly expressed in giant cell tumors of bone, as well as NFATc1 protein. Sequencing of exon 9 of SH3BP2 was normal in all sporadic nonsyndromic giant cell lesions. Although many multinucleated giant cell lesions of bone share histologic features, the primary genetic defect in cherubism and these other giant cell lesions appears different.

AB - Giant cell tumor of bone and giant cell reparative granuloma are benign lesions with prominent giant (multinucleated) cells, and an understanding of the molecular biology and genetics of these lesions will likely aid in more effective treatment. Cherubism is a benign lesion of the maxilla and mandible histologically similar to giant cell tumor of bone and giant cell reparative granuloma. Germline mutations in exon 9 of the gene encoding Src homology 3 binding protein 2 (SH3BP2) occur in most patients with cherubism. We therefore hypothesized SH3BP2 and its putative downstream effector nuclear factor of activated T cells c1 isoform (NFATc1) are highly expressed in sporadic nonsyndromic giant cell lesions and associated with somatic SH3BP2 mutations. We analyzed giant cell lesions for SH3BP2 and NFATc1 expression by RNA blot and/or immunohistochemistry and for exon 9 SH3BP2 mutations. We found the SH3BP2 transcripts and protein were abundantly expressed in giant cell tumors of bone, as well as NFATc1 protein. Sequencing of exon 9 of SH3BP2 was normal in all sporadic nonsyndromic giant cell lesions. Although many multinucleated giant cell lesions of bone share histologic features, the primary genetic defect in cherubism and these other giant cell lesions appears different.

UR - http://www.scopus.com/inward/record.url?scp=34249931805&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34249931805&partnerID=8YFLogxK

U2 - 10.1097/BLO.0b013e31804b4131

DO - 10.1097/BLO.0b013e31804b4131

M3 - Article

C2 - 17545756

AN - SCOPUS:34249931805

SP - 22

EP - 27

JO - Clinical Orthopaedics and Related Research

JF - Clinical Orthopaedics and Related Research

SN - 0009-921X

IS - 459

ER -